Literature DB >> 29482780

Diet and supplements in cancer prevention and treatment: Clinical evidences and future perspectives.

Claudio Vernieri1, Federico Nichetti2, Alessandra Raimondi2, Sara Pusceddu2, Marco Platania2, Franco Berrino3, Filippo de Braud4.   

Abstract

In recent years, calorie-restricted dietary regimens and compounds such as vitamins, curcumin, green tea extracts and omega-3 fatty acids have attracted attention for their potential anticancer effects. While definitive conclusions cannot be drawn in this field, many patients adopt complementary antitumor therapies aiming to improve efficacy or reduce toxicity of chemotherapy, with uncertain benefits and the risk of additional toxicities or antagonistic interactions with standard therapies. In this manuscript, we review the different levels of available evidence to suggest or discourage specific dietary changes or supplement use in the context of cancer prevention, reduction of tumor recurrences and survival prolongation in advanced cancers. Preventing or treating obesity, as well as adhering to healthy dietary patterns, should be recommended to both the general population and cancer survivors because they are convincingly associated with reduced risk of primary or second cancers and, in some cases, with reduced cancer recurrences. On the contrary, the role of specific interventions or supplements in patients with advanced malignancies is much more uncertain and actually a highly debated topic. With some exceptions, such as melatonin, the use of most complementary therapies cannot be encouraged, or should be discouraged, because of the lack of sufficient safety and efficacy data.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer prevention; Cancer treatment; Complementary therapies; Diet; Dietary supplements; Obesity

Mesh:

Substances:

Year:  2018        PMID: 29482780     DOI: 10.1016/j.critrevonc.2018.01.002

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  7 in total

1.  Health and Economics of Lifestyle Medicine Strategies.

Authors:  Dee W Edington; Wayne N Burton; Alyssa B Schultz
Journal:  Am J Lifestyle Med       Date:  2020-02-22

2.  Dietary regulation of metastasis.

Authors:  Jonathan P Sleeman
Journal:  Clin Exp Metastasis       Date:  2018-12       Impact factor: 5.150

3.  Evening Primrose Oil Improves Chemotherapeutic Effects in Human Pancreatic Ductal Adenocarcinoma Cell Lines-A Preclinical Study.

Authors:  Laura Zeppa; Cristina Aguzzi; Giorgia Versari; Margherita Luongo; Maria Beatrice Morelli; Federica Maggi; Consuelo Amantini; Giorgio Santoni; Oliviero Marinelli; Massimo Nabissi
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-12

4.  Trends in integrative medicine and health consults: differences between cancer survivors and patients without cancer.

Authors:  Noël M Arring; Denise Millstine; Debra L Barton; Karen S Lyons; Marlene Girardo; Amy Hutson; Lillian M Nail
Journal:  Support Care Cancer       Date:  2020-10-14       Impact factor: 3.603

5.  Therapeutic strategies of melatonin in cancer patients: a systematic review and meta-analysis.

Authors:  Yi Wang; Pengcheng Wang; Xiaoli Zheng; Xing Du
Journal:  Onco Targets Ther       Date:  2018-11-08       Impact factor: 4.147

6.  Altered Red Blood Cell Membrane Fatty Acid Profile in Cancer Patients.

Authors:  Javier Amézaga; Sara Arranz; Ander Urruticoechea; Gurutze Ugartemendia; Aitziber Larraioz; Maria Louka; Matxalen Uriarte; Carla Ferreri; Itziar Tueros
Journal:  Nutrients       Date:  2018-12-01       Impact factor: 5.717

Review 7.  A Narrative Review of the Safety of Anti-COVID-19 Nutraceuticals for Patients with Cancer.

Authors:  Karlen Stade Bader-Larsen; Elisabeth Anne Larson; Maria Dalamaga; Faidon Magkos
Journal:  Cancers (Basel)       Date:  2021-12-03       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.